| RS2104860667 |
FBXO11
|
Health Risk |
Likely pathogenic |
Intellectual developmental disorder with dysmorphic facies and behavioral abnormalities, Intellectual developmental disorder with dysmorphic facies and behavioral abnormalities |
| RS2104871303 |
SMPD4
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder with microcephaly, arthrogryposis |
| RS2104879312 |
RAB3GAP1
|
Health Risk |
Likely pathogenic |
Warburg micro syndrome, Warburg micro syndrome |
| RS2104884982 |
CKAP2L
|
Health Risk |
Pathogenic/Likely pathogenic |
Filippi syndrome, Filippi syndrome |
| RS2104908342 |
HS6ST1
|
Health Risk |
risk factor |
Hypogonadotropic hypogonadism 15 with anosmia, Hypogonadotropic hypogonadism 15 with anosmia |
| RS2104915487 |
CXCR4
|
Health Risk |
Pathogenic |
Warts, hypogammaglobulinemia |
| RS2104915503 |
CXCR4
|
Health Risk |
Likely pathogenic |
— |
| RS2104915518 |
CXCR4
|
Health Risk |
Pathogenic |
Warts, hypogammaglobulinemia |
| RS2104915543 |
CXCR4
|
Health Risk |
Pathogenic |
Warts, hypogammaglobulinemia |
| RS2104915548 |
CXCR4
|
Health Risk |
Pathogenic |
Warts, hypogammaglobulinemia |
| RS2104915575 |
CXCR4
|
Health Risk |
Pathogenic |
Warts, hypogammaglobulinemia |
| RS2104915614 |
CXCR4
|
Health Risk |
Pathogenic |
— |
| RS2104915668 |
CXCR4
|
Health Risk |
Pathogenic |
Warts, hypogammaglobulinemia |
| RS2104915680 |
CXCR4
|
Health Risk |
Pathogenic |
Warts, hypogammaglobulinemia |
| RS2104916488 |
RAB3GAP1
|
Health Risk |
Pathogenic |
Warburg micro syndrome 1, Martsolf syndrome 2 |
| RS2104919976 |
ABCG8
|
Health Risk |
Pathogenic |
— |
| RS2104934553 |
PROC
|
Health Risk |
Pathogenic |
Thrombophilia due to protein C deficiency, autosomal dominant |
| RS2104935838 |
BIN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Myopathy, centronuclear |
| RS2104943498 |
RAB3GAP1
|
Health Risk |
Likely pathogenic |
Warburg micro syndrome 1, Warburg micro syndrome 1 |
| RS2104947166 |
ABCG8
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS2104947953 |
ABCG8
|
Health Risk |
Likely pathogenic |
— |
| RS2104948584 |
RAB3GAP1
|
Health Risk |
Pathogenic |
— |
| RS2104953327 |
PROC
|
Health Risk |
Pathogenic |
Thrombophilia due to protein C deficiency, autosomal dominant |
| RS2104954798 |
PROC
|
Health Risk |
Likely pathogenic |
Thrombophilia due to protein C deficiency, autosomal dominant |
| RS2104954946 |
PROC
|
Health Risk |
Likely pathogenic |
Reduced protein C activity, Reduced protein C activity |
| RS2104970514 |
LRPPRC
|
Health Risk |
Pathogenic |
— |
| RS2104983369 |
RAB3GAP1
|
Health Risk |
Pathogenic |
Warburg micro syndrome 1, Warburg micro syndrome 1 |
| RS2104984579 |
PROC
|
Health Risk |
Likely pathogenic |
— |
| RS2104989326 |
LRPPRC
|
Health Risk |
Pathogenic |
— |
| RS2104989806 |
LRPPRC
|
Health Risk |
Pathogenic |
— |
| RS2104989966 |
LRPPRC
|
Health Risk |
Pathogenic |
— |
| RS2104990067 |
LRPPRC
|
Health Risk |
Pathogenic |
— |
| RS2104990962 |
CTNNA2
|
Health Risk |
Pathogenic |
Hereditary breast ovarian cancer syndrome, Hereditary breast ovarian cancer syndrome |
| RS2105001159 |
RAB3GAP1
|
Health Risk |
Pathogenic |
Martsolf syndrome 2, Martsolf syndrome 2 |
| RS2105019803 |
GLI2
|
Health Risk |
Likely pathogenic |
Postaxial polydactyly-anterior pituitary anomalies-facial dysmorphism syndrome, Postaxial polydactyly-anterior pituitary anomalies-facial dysmorphism syndrome |
| RS2105026015 |
LRPPRC
|
Health Risk |
Pathogenic |
— |
| RS2105042210 |
MMADHC
|
Health Risk |
Pathogenic |
Methylmalonic aciduria and homocystinuria type cblD, Methylmalonic aciduria and homocystinuria type cblD |
| RS2105042238 |
MMADHC
|
Health Risk |
Pathogenic/Likely pathogenic |
Methylmalonic aciduria and homocystinuria type cblD, Methylmalonic aciduria and homocystinuria type cblD |
| RS2105042265 |
MMADHC
|
Health Risk |
Pathogenic |
Methylmalonic aciduria and homocystinuria type cblD, Methylmalonic aciduria and homocystinuria type cblD |
| RS2105045491 |
MMADHC
|
Health Risk |
Pathogenic |
Methylmalonic aciduria and homocystinuria type cblD, Methylmalonic aciduria and homocystinuria type cblD |
| RS2105048127 |
MMADHC
|
Health Risk |
Pathogenic |
Methylmalonic aciduria and homocystinuria type cblD, Methylmalonic aciduria and homocystinuria type cblD |
| RS2105059931 |
PTPN4
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder, Neurodevelopmental disorder |
| RS2105073672 |
FAM161A
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa 28, Retinitis pigmentosa 28 |
| RS2105073699 |
FAM161A
|
Health Risk |
Pathogenic |
— |
| RS2105073705 |
FAM161A
|
Health Risk |
Pathogenic |
— |
| RS2105073741 |
FAM161A
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa 28, Retinitis pigmentosa 28 |
| RS2105073911 |
FAM161A
|
Health Risk |
Pathogenic |
— |
| RS2105077267 |
LRPPRC
|
Health Risk |
Likely pathogenic |
— |
| RS2105077465 |
LRPPRC
|
Health Risk |
Pathogenic/Likely pathogenic |
Congenital lactic acidosis, Saguenay-Lac-Saint-Jean type |
| RS2105077651 |
LRPPRC
|
Health Risk |
Pathogenic/Likely pathogenic |
Congenital lactic acidosis, Saguenay-Lac-Saint-Jean type |
| RS2105077791 |
LRPPRC
|
Health Risk |
Pathogenic |
— |
| RS2105077920 |
FAM161A
|
Health Risk |
Pathogenic |
— |
| RS2105077955 |
FAM161A
|
Health Risk |
Pathogenic |
— |
| RS2105080409 |
FAM161A
|
Health Risk |
Pathogenic |
— |
| RS2105080547 |
FAM161A
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa 28, Retinitis pigmentosa 28 |
| RS2105080565 |
FAM161A
|
Health Risk |
Pathogenic |
— |
| RS2105080679 |
FAM161A
|
Health Risk |
Pathogenic |
— |
| RS2105080750 |
FAM161A
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS2105080884 |
FAM161A
|
Health Risk |
Pathogenic |
— |
| RS2105080891 |
LRPPRC
|
Health Risk |
Pathogenic |
— |
| RS2105080958 |
FAM161A
|
Health Risk |
Pathogenic |
— |
| RS2105080977 |
FAM161A
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa 28, Retinitis pigmentosa 28 |
| RS2105081186 |
FAM161A
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinal dystrophy, Retinal dystrophy |
| RS2105081486 |
FAM161A
|
Health Risk |
Pathogenic |
— |
| RS2105082121 |
FAM161A
|
Health Risk |
Pathogenic |
— |
| RS2105082215 |
FAM161A
|
Health Risk |
Pathogenic |
— |
| RS2105082218 |
FAM161A
|
Health Risk |
Pathogenic |
— |
| RS2105082415 |
FAM161A
|
Health Risk |
Pathogenic |
— |
| RS2105082548 |
LRPPRC
|
Health Risk |
Pathogenic |
— |
| RS2105082909 |
FAM161A
|
Health Risk |
Pathogenic |
— |
| RS2105082959 |
FAM161A
|
Health Risk |
Pathogenic |
— |
| RS2105083232 |
FAM161A
|
Health Risk |
Pathogenic |
— |
| RS2105083646 |
FAM161A
|
Health Risk |
Pathogenic |
— |
| RS2105083980 |
FAM161A
|
Health Risk |
Pathogenic |
— |
| RS2105084620 |
GLI2
|
Health Risk |
Pathogenic |
Postaxial polydactyly-anterior pituitary anomalies-facial dysmorphism syndrome, Postaxial polydactyly-anterior pituitary anomalies-facial dysmorphism syndrome |
| RS2105084665 |
GLI2
|
Health Risk |
Pathogenic |
— |
| RS2105084937 |
LRPPRC
|
Health Risk |
Pathogenic |
— |
| RS2105085199 |
GLI2
|
Health Risk |
Pathogenic |
Cerebellar cyst, Cerebellar cyst |
| RS2105085236 |
LRPPRC
|
Health Risk |
Likely pathogenic |
Congenital lactic acidosis, Saguenay-Lac-Saint-Jean type |
| RS2105086549 |
FAM161A
|
Health Risk |
Pathogenic |
— |
| RS2105086622 |
FAM161A
|
Health Risk |
Pathogenic |
— |
| RS2105086630 |
FAM161A
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa 28, Retinitis pigmentosa 28 |
| RS2105086979 |
FAM161A
|
Health Risk |
Pathogenic |
— |
| RS2105091650 |
KIF5C
|
Health Risk |
Pathogenic/Likely pathogenic |
Complex cortical dysplasia with other brain malformations 2, Complex cortical dysplasia with other brain malformations 2 |
| RS2105093302 |
MBD5
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 1 |
| RS2105093530 |
MBD5
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability, autosomal dominant 1 |
| RS2105111147 |
FAM161A
|
Health Risk |
Pathogenic |
— |
| RS2105111295 |
FAM161A
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa 28 |
| RS2105111520 |
FAM161A
|
Health Risk |
Pathogenic |
— |
| RS2105123510 |
MBD5
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 1 |
| RS2105124073 |
MBD5
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 1 |
| RS2105124818 |
MBD5
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 1 |
| RS2105129435 |
MBD5
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability, autosomal dominant 1 |
| RS2105130509 |
MBD5
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 1 |
| RS2105131625 |
MBD5
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 1 |
| RS2105148069 |
FANCL
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia |
| RS2105154353 |
LRP1B
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2105187668 |
LRP1B
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2105192046 |
IFIH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Aicardi-Goutieres syndrome 7, Singleton-Merten syndrome 1 |
| RS2105197765 |
IFIH1
|
Health Risk |
Pathogenic |
Neurodevelopmental delay, Neurodevelopmental delay |